跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mefenak - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Mefenak
Approved
STANDARD
Mefenak
Azarias Pharmaceutical Laboratories Inc.,
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
37cd568237c81d07
Company
Azarias Pharmaceutical Laboratories Inc.,
Type
Standard
Approval Details
Approval Id
37cd568237c81d07
Drug Approval Philippines Name
Mefenak
Product Name
Mefenak
Registration Number
DRP-5390-06
Brand Name
Mefenak
Generic Name
Mefenamic Acid
Dosage Form
Capsule
Dosage Strength
500 mg
Manufacturer
Azarias Pharmaceutical Laboratories Inc.,
Distributor
St. Raphael Archangel Pharmaceutical Product Distribution
Issuance Date
25 July 2024
Expiry Date
11 July 2029
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug (NSAID)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
37cd568237c81d07
Type
Standard
Back to Philippines FDA Approvals